buspirone has been researched along with Chronic Kidney Failure in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Excerpt | Relevance | Reference |
---|---|---|
" The differences between the median pharmacokinetic values of buspirone for healthy subjects, patients with mild to moderate renal impairment, and anuric patients were not statistically significant." | 1.27 | Clinical pharmacokinetics of oral buspirone in patients with impaired renal function. ( Caccia, S; Gammans, RE; Garattini, S; Mayol, RF; Mingardi, G; Pfeffer, M; Placchi, M; Vigano, GL, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caccia, S | 1 |
Vigano, GL | 1 |
Mingardi, G | 1 |
Garattini, S | 1 |
Gammans, RE | 1 |
Placchi, M | 1 |
Mayol, RF | 1 |
Pfeffer, M | 1 |
1 other study available for buspirone and Chronic Kidney Failure
Article | Year |
---|---|
Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.
Topics: Administration, Oral; Adult; Buspirone; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Ki | 1988 |